Artificial intelligence (AI) has significantly impacted thyroid cancer diagnosis in recent years,
offering advanced tools and methodologies that promise to revolutionize patient outcomes …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Background We aimed to investigate whether the risk of second primary malignancy (SPM)
in patients with thyroid cancer (TC) receiving radioactive iodine (RAI) therapy rises in a …

Epidemiologic data suggest that cancer survivors tend to develop a protuberant number of
adverse late effects, including second primary malignancies (SPM), as a result of cytotoxic …

Radioactive iodine (RAI) therapy with iodine-131 is performed in select cases of
differentiated thyroid cancer (DTC), typically for remnant ablation, adjuvant therapy, or …

The growing interest in developing smart diagnostic systems to help medical experts
process extensive data for treating incurable diseases has been notable. In particular, the …

Few studies have found an association between statin use and head and neck cancer
(HNC) outcomes. We examined the effect of statin use on HNC recurrence using the …

The number of cancer survivors worldwide is increasing every year, making secondary
primary cancers (SPC) is a growing health threat. Studies have been conducted to …

Second primary malignancies (SPM) are described as any primary, not synchronous,
malignancy arising in a different anatomical district, with confirmed histological diagnosis …

Purpose To investigate the risk factors of second primary malignant tumor (SPMT) in patients
with differentiated thyroid cancer (DTC) and establish a competing risk nomogram to predict …